A daily dose of 400 mg efavirenz (EFV) is non-inferior to the standard 600 mg dose: week 48 data from the ENCORE1 study, a randomised, double-blind, placebo.
Gordie McCarty [email protected] Professional licenses Contractor and Real Estate Agent.
Encore1 study design
